← Leaderboards
David Corley Gibbs
Emory University
$184,865
Attributed
$184,865
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2019–22$100K$75K$50K$25K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$184,865 · 1
By mechanism
F30$184,865 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Jessica Alejandra Alvarez$6,822,607
- David Michael Schuster$5,425,562
- Ashesh Jani$3,084,487
- Matthew James Magee$4,633,632
- Veronika Fedirko$6,615,038
Others in their field
Other Emerging Leaders on “Antineoplastic Agents”
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,796,285
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$29,626,259
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Jeffrey H. Price · Vala Sciences, Inc.$5,562,326
Research focus
Antineoplastic AgentsBaseBinding ProteinsBiologicalBiological MarkersBiopsyBloodCalcifediolCancer Cell LineCancer EtiologyCancer SurvivalCessation Of LifeClinical TrialsColon Cancer RiskColon CarcinomaColorectalColorectal AdenomaColorectal CancerColorectal Cancer RiskColorectal NeoplasmsControlled Clinical TrialsCyclooxygenase 2Double-Blind MethodAffect
Grant awards (4)
Biomarkers of Inflammation, Vitamin D, and Colorectal Cancer Risk and Survival$35,933
F30 · FY2022 · CA · contact PI
Biomarkers of Inflammation, Vitamin D, and Colorectal Cancer Risk and Survival$48,396
F30 · FY2021 · CA · contact PI
Biomarkers of Inflammation, Vitamin D, and Colorectal Cancer Risk and Survival$50,520
F30 · FY2020 · CA · contact PI
Biomarkers of Inflammation, Vitamin D, and Colorectal Cancer Risk and Survival$50,016
F30 · FY2019 · CA · contact PI